ANI Pharmaceuticals, Inc.
ANIP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $27 | $9 | $16 | -$10 |
| Dep. & Amort. | $23 | $23 | $23 | $23 |
| Deferred Tax | $19 | -$4 | -$3 | -$18 |
| Stock-Based Comp. | $10 | $10 | $9 | $7 |
| Change in WC | -$18 | $36 | $1 | -$5 |
| Other Non-Cash | -$16 | $2 | -$10 | $19 |
| Operating Cash Flow | $44 | $76 | $35 | $16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$4 | -$2 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | -$8 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$0 | -$3 | -$17 | -$0 |
| Investing Cash Flow | -$6 | -$7 | -$20 | -$11 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2 | -$2 | -$2 | $37 |
| Stock Issued | $0 | $0 | $0 | $2 |
| Stock Repurch. | $0 | $0 | -$10 | -$0 |
| Dividends Paid | -$0 | -$0 | -$0 | -$0 |
| Other Fin. Act. | $9 | $1 | $3 | -$42 |
| Financing Cash Flow | $6 | -$2 | -$10 | -$5 |
| Forex Effect | $1 | $1 | -$0 | -$0 |
| Net Chg. in Cash | $45 | $68 | $5 | -$0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $218 | $150 | $145 | $145 |
| End Cash | $263 | $218 | $150 | $145 |
| Free Cash Flow | $38 | $69 | $15 | $13 |